XML 34 R22.htm IDEA: XBRL DOCUMENT

Insider Trading Arrangements	3 Months Ended	6 Months Ended
Insider Trading Arrangements	Jun. 30, 2024 shares	Jun. 30, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On May 23, 2024, Joseph M. Fitzgerald, our Executive Vice President and Group President, Cardiology, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Mr. Fitzgerald’s plan covers the sale of 553,370 shares of our common stock, including 492,532 shares to be acquired upon exercise of stock options. Transactions under Mr. Fitzgerald’s plan are based upon pre-established dates and stock price thresholds and will only occur upon the expiration of the applicable mandatory cooling-off period. Mr. Fitzgerald’s plan will terminate on the earlier of May 20, 2026, or the date all shares subject to the plan have been sold.
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Joseph M. Fitzgerald [Member]
Trading Arrangements, by Individual
Name	Joseph M. Fitzgerald
Title	Executive Vice President and Group President
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	May 23, 2024
Vance R. Brown [Member]
Trading Arrangements, by Individual
Arrangement Duration	727 days
Rule Trading Arrangement, Common Stock [Member] \| Joseph M. Fitzgerald [Member]
Trading Arrangements, by Individual
Aggregate Available	553,370	553,370
Rule Trading Arrangement Stock Appreciation Right [Member] \| Joseph M. Fitzgerald [Member]
Trading Arrangements, by Individual
Aggregate Available	492,532	492,532